{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"ddx41-related-hematologic-malignancy-predisposition-syndrome","columns":[{"gene":"","key":"MONDO:0014809/OMIM:616871","label":"Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to","mondoId":"MONDO:0014809","onsetQualifier":null,"recordKeys":["055dbde9f284ebb6ea9c0a77c072dac1146108fa5c382a3d135403adc451f832","1296ba56f30c67ca4d7eb786de359219c547c26500892dc8ed5b9de00e280a33","26733c717dae4ea345f76bd880d4d5c3ca0fe65ea25906bb924ad4185ffef64d","44d48b04771c9648a871da0f062eae8bd7c3995747dd333023b92cf61cb2c2b0","45f6f9669401fb877ddb5501b4f813772fe005d9cbdfb77ff1f68b96090c373f","5b55589447db9fc81083a3e1caac0b34c74b3e5308c8097253f2747f62586a89","6813a5dead2c23a58d11064cfd5f2a928cd193aaa8a196e0baf0a8b6d531a3ba","8236cfb7d316debb120124a89b65c9e423033bb5f93d1e0ef8a0e589cd5efa2f","ab6219e6be8c74ad8eeea9b58dd43387aec0a86fd5862b591d95cb58f65286d1","d6d9cae08fc2e1133145e119d25cfa4a0098ec45df710a65aaa005c3e54fe27b","daf5fac6a075a8daa5ad5c1ac2cbd72e9ffd8201092e56eba0b10f2939efec56"],"recordQualifiers":{},"scopeLabel":"OMIM:616871","sourceIds":["OMIM:616871"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0014809/OMIM:616871"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":11,"sourceGroups":{"omim":5,"orphanet":0,"published":6}},"features":[{"hpoId":"HP:0004808","label":"Acute myeloid leukemia","primary":false},{"hpoId":"HP:0002099","label":"Asthma","primary":false},{"hpoId":"HP:0005528","label":"Bone marrow hypocellularity","primary":false},{"hpoId":"HP:0001882","label":"Decreased total leukocyte count","primary":false},{"hpoId":"HP:0000964","label":"Eczematoid dermatitis","primary":false},{"hpoId":"HP:0031688","label":"Erythroid dysplasia","primary":false},{"hpoId":"HP:0012311","label":"Increased total monocyte count","primary":false},{"hpoId":"HP:0002665","label":"Lymphoma","primary":false},{"hpoId":"HP:0002863","label":"Myelodysplasia","primary":false},{"hpoId":"HP:0005505","label":"Refractory anemia","primary":false},{"hpoId":"HP:0002725","label":"Systemic lupus erythematosus","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0014809","records":[{"frequencyKind":"reported","key":"055dbde9f284ebb6ea9c0a77c072dac1146108fa5c382a3d135403adc451f832","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616871","disease_name":"Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0031688","is_excluded":false,"label":"Erythroid dysplasia","onset_id":null,"reference":"OMIM:616871","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"1296ba56f30c67ca4d7eb786de359219c547c26500892dc8ed5b9de00e280a33","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616871","disease_name":"Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0005528","is_excluded":false,"label":"Bone marrow hypocellularity","onset_id":null,"reference":"PMID:26712909","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"26733c717dae4ea345f76bd880d4d5c3ca0fe65ea25906bb924ad4185ffef64d","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616871","disease_name":"Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002665","is_excluded":false,"label":"Lymphoma","onset_id":null,"reference":"OMIM:616871","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"44d48b04771c9648a871da0f062eae8bd7c3995747dd333023b92cf61cb2c2b0","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:616871","disease_name":"Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002099","is_excluded":false,"label":"Asthma","onset_id":null,"reference":"OMIM:616871","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"45f6f9669401fb877ddb5501b4f813772fe005d9cbdfb77ff1f68b96090c373f","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:616871","disease_name":"Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002725","is_excluded":false,"label":"Systemic lupus erythematosus","onset_id":null,"reference":"OMIM:616871","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5b55589447db9fc81083a3e1caac0b34c74b3e5308c8097253f2747f62586a89","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616871","disease_name":"Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002863","is_excluded":false,"label":"Myelodysplasia","onset_id":null,"reference":"PMID:25920683","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"6813a5dead2c23a58d11064cfd5f2a928cd193aaa8a196e0baf0a8b6d531a3ba","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616871","disease_name":"Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0005505","is_excluded":false,"label":"Refractory anemia","onset_id":null,"reference":"PMID:25920683","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"8236cfb7d316debb120124a89b65c9e423033bb5f93d1e0ef8a0e589cd5efa2f","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616871","disease_name":"Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0012311","is_excluded":false,"label":"Increased total monocyte count","onset_id":null,"reference":"PMID:25920683","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ab6219e6be8c74ad8eeea9b58dd43387aec0a86fd5862b591d95cb58f65286d1","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616871","disease_name":"Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001882","is_excluded":false,"label":"Decreased total leukocyte count","onset_id":null,"reference":"PMID:26712909","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"d6d9cae08fc2e1133145e119d25cfa4a0098ec45df710a65aaa005c3e54fe27b","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:616871","disease_name":"Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000964","is_excluded":false,"label":"Eczematoid dermatitis","onset_id":null,"reference":"OMIM:616871","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"daf5fac6a075a8daa5ad5c1ac2cbd72e9ffd8201092e56eba0b10f2939efec56","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616871","disease_name":"Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0004808","is_excluded":false,"label":"Acute myeloid leukemia","onset_id":null,"reference":"PMID:25920683","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"ddx41-related-hematologic-malignancy-predisposition","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"DDX41-related hematologic malignancy predisposition syndrome"},"schemaVersion":1}